Market Tracker

02/23 1:28pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.30
BATS BZX Real-Time Price
As of 1:27pm ET
 +0.03 / +0.92%
Today’s Change
2.85
Today|||52-Week Range
8.75
-6.78%
Year-to-Date

Today’s Trading

Previous close3.27
Today’s open3.28
Day’s range3.27 - 3.36
Volume65,330
Average volume (3 months)2,067,199
Market cap$399.8M
Dividend yield--
Data as of 1:27pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.40%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...0.000.00%
OXFDOxford Immunotec Glo...+0.20+1.50%
IMMUImmunomedics Inc-0.03-0.60%
VIVOMeridian Bioscience ...+0.32+2.60%
Data as of 1:27pm ET, 02/23/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts